Comments: NY S04808 | 2019-2020 | General Assembly

Bill Title: Prohibits certain insurance policies from requiring prior authorization for buprenorphine products, methadone and long acting injectable naltrexone for detoxification or maintenance treatment of substance use disorders.

Spectrum: Partisan Bill (Democrat 5-0)

Status: (Passed) 2019-12-31 - signed chap.748 [S04808 Detail]

Text: Latest bill text (Introduced) [HTML]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2019 New York S04808 at this time.

Social Comments on NY S04808

feedback